Literature DB >> 30430547

Evaluation of the Dermatology Life Quality Index scoring modification, the DLQI-R score, in two independent populations.

J S Barbieri1, J M Gelfand1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30430547      PMCID: PMC6443498          DOI: 10.1111/bjd.17419

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

Review 1.  The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results.

Authors:  M K A Basra; R Fenech; R M Gatt; M S Salek; A Y Finlay
Journal:  Br J Dermatol       Date:  2008-09-15       Impact factor: 9.302

2.  Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.

Authors:  Joel M Gelfand; Joy Wan; Kristina Callis Duffin; Gerald G Krueger; Robert E Kalb; Jamie D Weisman; Brian R Sperber; Michael B Stierstorfer; Bruce A Brod; Stephen M Schleicher; Bruce F Bebo; Andrea B Troxel; Daniel B Shin; Jane M Steinemann; Jennifer Goldfarb; Howa Yeung; Abby S Van Voorhees
Journal:  Arch Dermatol       Date:  2012-04

3.  Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial.

Authors:  Nehal N Mehta; Daniel B Shin; Aditya A Joshi; Amit K Dey; April W Armstrong; Kristina Callis Duffin; Zelma Chiesa Fuxench; Charlotte L Harrington; Rebecca A Hubbard; Robert E Kalb; Alan Menter; Daniel J Rader; Muredach P Reilly; Eric L Simpson; Junko Takeshita; Drew A Torigian; Thomas J Werner; Andrea B Troxel; Stephen K Tyring; Suzette Baez Vanderbeek; Abby S Van Voorhees; Martin P Playford; Mark A Ahlman; Abass Alavi; Joel M Gelfand
Journal:  Circ Cardiovasc Imaging       Date:  2018-06       Impact factor: 7.792

4.  Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis.

Authors:  F Rencz; L Gulácsi; M Péntek; A K Poór; M Sárdy; P Holló; A Szegedi; É Remenyik; V Brodszky
Journal:  Br J Dermatol       Date:  2018-09-19       Impact factor: 9.302

5.  Definition of treatment goals for moderate to severe psoriasis: a European consensus.

Authors:  U Mrowietz; K Kragballe; K Reich; P Spuls; C E M Griffiths; A Nast; J Franke; C Antoniou; P Arenberger; F Balieva; M Bylaite; O Correia; E Daudén; P Gisondi; L Iversen; L Kemény; M Lahfa; T Nijsten; T Rantanen; A Reich; T Rosenbach; S Segaert; C Smith; T Talme; B Volc-Platzer; N Yawalkar
Journal:  Arch Dermatol Res       Date:  2010-09-21       Impact factor: 3.017

  5 in total
  4 in total

1.  Responsiveness of the EuroQol 5-Dimension 3-Level instrument, Dermatology Life Quality Index (DLQI) and DLQI-Relevant for patients with psoriasis in the U.S.A.

Authors:  J S Barbieri; J M Gelfand
Journal:  Br J Dermatol       Date:  2019-08-06       Impact factor: 9.302

2.  Influence of "Not Relevant" Responses on the Dermatology Life Quality Index (DLQI) for Patients With Psoriasis in the United States.

Authors:  John S Barbieri; Joel M Gelfand
Journal:  JAMA Dermatol       Date:  2019-06-01       Impact factor: 10.282

3.  Frequency and influence of "not relevant" responses on the Dermatology Life Quality Index among adults with atopic dermatitis.

Authors:  John S Barbieri; Zelma C Chiesa Fuxench; Daniel B Shin; Junko Takeshita
Journal:  Qual Life Res       Date:  2021-02-04       Impact factor: 3.440

Review 4.  Counting the Burden: Atopic Dermatitis and Health-related Quality of Life.

Authors:  Faraz Ali; Jui Vyas; Andrew Y Finlay
Journal:  Acta Derm Venereol       Date:  2020-06-09       Impact factor: 3.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.